Home › Funds › Capital Research Global Investors › PCVX
Capital Research Global Investors position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)836.76K sh
Reported value held$48.64M
Portfolio Weight0.01%
First reportedQ3 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 514.86K | $12.68M | New |
| Q4 2022 | 2.81M | $134.55M | Add |
| Q1 2023 | 2.85M | $106.93M | Add |
| Q2 2023 | 3.36M | $168.00M | Add |
| Q3 2023 | 3.36M | $171.50M | Hold |
| Q4 2023 | 3.44M | $216.04M | Add |
| Q1 2024 | 4.14M | $282.84M | Add |
| Q2 2024 | 4.13M | $312.12M | Hold |
| Q3 2024 | 4.90M | $559.72M | Add |
| Q4 2024 | 6.21M | $508.39M | Add |
| Q1 2025 | 6.11M | $230.72M | Reduce |
| Q2 2025 | 4.77M | $155.13M | Reduce |
| Q3 2025 | 842.98K | $30.36M | Reduce |
| Q4 2025 | 842.98K | $38.90M | Hold |
| Q1 2026 | 912.69K | $53.04M | Add |
| Q2 2026 | 836.76K | $48.64M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026